Eliem Therapeutics Price Prediction
| ELYMDelisted Stock | USD 3.04 0.04 1.30% |
Oversold Vs Overbought
32
Oversold | Overbought |
Using Eliem Therapeutics hype-based prediction, you can estimate the value of Eliem Therapeutics from the perspective of Eliem Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Eliem Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Eliem because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Eliem Therapeutics after-hype prediction price | USD 3.34 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Eliem |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eliem Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Eliem Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Eliem Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Eliem Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Eliem Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Eliem Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Eliem Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Eliem Therapeutics' historical news coverage. Eliem Therapeutics' after-hype downside and upside margins for the prediction period are 0.17 and 8.17, respectively. We have considered Eliem Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Eliem Therapeutics is very risky at this time. Analysis and calculation of next after-hype price of Eliem Therapeutics is based on 3 months time horizon.
Eliem Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Eliem Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Eliem Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Eliem Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.19 | 4.83 | 0.30 | 0.04 | 4 Events / Month | 13 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.04 | 3.34 | 9.87 |
|
Eliem Therapeutics Hype Timeline
Eliem Therapeutics is currently traded for 3.04. The entity has historical hype elasticity of 0.3, and average elasticity to hype of competition of 0.04. Eliem is anticipated to increase in value after the next headline, with the price projected to jump to 3.34 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 9.87%, whereas the daily expected return is currently at -1.19%. The volatility of related hype on Eliem Therapeutics is about 13033.33%, with the expected price after the next announcement by competition of 3.08. The company has return on total asset (ROA) of (0.2454) % which means that it has lost $0.2454 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3835) %, meaning that it created substantial loss on money invested by shareholders. Eliem Therapeutics' management efficiency ratios could be used to measure how well Eliem Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Given the investment horizon of 90 days the next anticipated press release will be in about 4 days. Check out Eliem Therapeutics Basic Forecasting Models to cross-verify your projections.Eliem Therapeutics Related Hype Analysis
Having access to credible news sources related to Eliem Therapeutics' direct competition is more important than ever and may enhance your ability to predict Eliem Therapeutics' future price movements. Getting to know how Eliem Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Eliem Therapeutics may potentially react to the hype associated with one of its peers.
Eliem Therapeutics Additional Predictive Modules
Most predictive techniques to examine Eliem price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Eliem using various technical indicators. When you analyze Eliem charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Eliem Therapeutics Predictive Indicators
The successful prediction of Eliem Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Eliem Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Eliem Therapeutics based on analysis of Eliem Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Eliem Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Eliem Therapeutics's related companies.
Story Coverage note for Eliem Therapeutics
The number of cover stories for Eliem Therapeutics depends on current market conditions and Eliem Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Eliem Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Eliem Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Eliem Therapeutics Short Properties
Eliem Therapeutics' future price predictability will typically decrease when Eliem Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Eliem Therapeutics often depends not only on the future outlook of the potential Eliem Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eliem Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 27 M | |
| Cash And Short Term Investments | 106.8 M |
Check out Eliem Therapeutics Basic Forecasting Models to cross-verify your projections. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Eliem Stock
If you are still planning to invest in Eliem Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eliem Therapeutics' history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Transaction History View history of all your transactions and understand their impact on performance |